- Forums
- ASX - By Stock
- AGN
- Ann: First Patient Dosed in Phase 2 Stroke Trial of ARG-007
Ann: First Patient Dosed in Phase 2 Stroke Trial of ARG-007, page-38
-
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGN (ASX) to my watchlist
|
|||||
Last
80.5¢ |
Change
0.005(0.63%) |
Mkt cap ! $99.57M |
Open | High | Low | Value | Volume |
80.0¢ | 80.5¢ | 77.0¢ | $91.65K | 116.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2000 | 79.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
80.0¢ | 17400 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 5098 | 0.780 |
2 | 14422 | 0.770 |
1 | 3159 | 0.765 |
3 | 6447 | 0.760 |
1 | 12717 | 0.755 |
Price($) | Vol. | No. |
---|---|---|
0.800 | 17400 | 1 |
0.820 | 15000 | 1 |
0.860 | 12334 | 2 |
0.890 | 20699 | 2 |
0.895 | 5233 | 2 |
Last trade - 10.38am 25/07/2024 (20 minute delay) ? |
Featured News
AGN (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online